Says planning to invest more than $10B of capital in U.S. over next decade to support expansion of new areas. Says “extremely pleased” with strong momentum across the portfolio. Comments taken from Q1 earnings conference call.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- Morning Movers: AbbVie, Alphabet rising following first quarter reports
- AbbVie’s Strong Financial Performance and Growth Potential Justifies Buy Rating
- AbbVie reports Q1 adjusted EPS $2.46, consensus $2.40
- AbbVie raises FY25 adjusted EPS view to $12.09-$12.29 from $11.99-$12.19
- Options Volatility and Implied Earnings Moves Today, April 25, 2025